Additive antileukemia effects by GFI1B- and BCR-ABL-specific siRNA in advanced phase chronic myeloid leukemic cells. (Q50890164)

24 March 2018

title

Additive antileukemia effects by GFI1B- and BCR-ABL-specific siRNA in advanced phase chronic myeloid leukemic cells. (English)

1 reference

24 March 2018

1 reference

M Koldehoff

1

1 reference

24 March 2018

J L Zakrzewski

series ordinal

2

1 reference

24 March 2018

D W Beelen

series ordinal

3

1 reference

24 March 2018

A H Elmaagacli

series ordinal

4

1 reference

24 March 2018

publication date

21 June 2013

1 reference

24 March 2018

published in

Cancer Gene Therapy

1 reference

24 March 2018

volume

20

1 reference

24 March 2018

page(s)

421-427

1 reference

24 March 2018

issue

7

1 reference

24 March 2018

https://scigraph.springernature.com/pub.10.1038/cgt.2013.31

exact match

0 references

cites work

Chronic Myeloid Leukemia — Advances in Biology and New Approaches to Treatment

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2013.31

Gene expression changes associated with progression and response in chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2013.31

Potential applications of RNA interference technology in the treatment of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2013.31

Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2013.31

Small interfering RNA against BCR-ABL transcripts sensitize mutated T315I cells to nilotinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2013.31

The Gfi-1B proto-oncoprotein represses p21WAF1 and inhibits myeloid cell differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2013.31

The human homologue (GFI1B) of the chicken GFI gene maps to chromosome 9q34.13-A locus frequently altered in hematopoietic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2013.31

Growth factor-independent 1B gene (GFI1B) is overexpressed in erythropoietic and megakaryocytic malignancies and increases their proliferation rate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2013.31

Growth factor independent 1b (Gfi1b) and a new splice variant of Gfi1b are highly expressed in patients with acute and chronic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2013.31

Gene profiling of growth factor independence 1B gene (Gfi-1B) in leukemic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2013.31

Estimating the relapse stage in chronic myeloid leukaemia patients after allogeneic stem cell transplantation by the amount of BCR-ABL fusion transcripts detected using a new real-time polymerase chain reaction method

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2013.31

Quantitative gene expression analysis in microdissected archival formalin-fixed and paraffin-embedded tumor tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2013.31

Expression of multidrug resistance 1 (MDR1), multidrug resistance-related protein 1 (MRP1), lung resistance protein (LRP), and breast cancer resistance protein (BCRP) genes and clinical outcome in childhood acute lymphoblastic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2013.31

Specific inhibition of bcr-abl gene expression by small interfering RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2013.31

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2013.31

Therapeutic application of small interfering RNA directed against bcr-abl transcripts to a patient with imatinib-resistant chronic myeloid leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2013.31

Inhibition of bcr-abl gene expression by small interfering RNA sensitizes for imatinib mesylate (STI571).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2013.31

Killing of leukemic cells with a BCR/ABL fusion gene by RNA interference (RNAi).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2013.31

Targeting of gene expression by siRNA in CML primary cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2013.31

On the art of identifying effective and specific siRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2013.31

Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2013.31

Chronic myeloid leukemia: mechanisms of blastic transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2013.31

Post-transcriptional mechanisms in BCR/ABL leukemogenesis: role of shuttling RNA-binding proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2013.31

Molecular pathogenesis of Philadelphia-positive chronic myeloid leukemia - is it all BCR-ABL?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2013.31

Gfi1b negatively regulates Rag expression directly and via the repression of FoxO1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2013.31

Inhibition of bcr-abl and/or c-abl gene expression by small interfering, double-stranded RNAs: cross-talk with cell proliferation factors and other oncogenes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2013.31

Chronic myeloid leukemia stem cell biology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2013.31

MYC in chronic myeloid leukemia: induction of aberrant DNA synthesis and association with poor response to imatinib.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2013.31

Phenotypic and gene expression diversity of malignant cells in human blast crisis chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2013.31

inferred from DOI database lookup

7 January 2021

based on heuristic

Targeting primary human leukaemia cells with RNA interference: Bcr-Abl targeting inhibits myeloid progenitor self-renewal in chronic myeloid leukaemia cells

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2013.31

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/CGT.2013.31

1 reference

24 March 2018

PubMed ID

23788109

1 reference

24 March 2018